Riskpilot← Back to searchSign inGet full accessDenzir AB
ABActiveOrg 5566372602Anderstorg 12Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20029 employees
Revenue 2025
SEK 5M
-14% vs 2024
EBITDA margin
5.4%
-69% vs 2024
Equity ratio
36.7%
Financial strength
Net profit 2025
SEK -12K
-7457% vs 2024
| Revenue | SEK 5M | -14% |
| EBITDA | SEK 270K | -69% |
| Net profit | SEK -12K | -7457% |
| Total assets | SEK 1,8M | -3% |
| Equity | SEK 662K | -2% |
| Employees | 9 | — |
Legal name
Denzir AB
Org number
5566372602
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
9 december 2002
Share capital
SEK 100 000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva tillverkning och försäljning av produkter inom medicin och dentalområdet samt idka därmed förenlig verksamhet.
Address
Anderstorg 12
Email
johan.lundmark@denzir.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 3 626 | 3 417 | 2 717 | 2 940 | 3 393 | 4 605 | 5 773 | 4 992 |
| Staff expenses | — | — | — | — | — | — | — | — | −2 860 | −2 975 |
| EBITDA | −198 | −274 | 208 | 395 | −1 716 | 1 110 | 658 | 741 | 868 | 270 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −5 | −5 | −5 | −5 | −5 | −51 |
| EBIT | −198 | −274 | 208 | 395 | −1 721 | 1 105 | 653 | 736 | 863 | 220 |
| Net financials | 1 | −3 | −9 | −3 | −1 | −1 | — | 5 | −4 | −12 |
| Profit before tax | 2 | 3 | 0 | 7 | −1 722 | 494 | 653 | 741 | 3 | −12 |
| Tax | −2 | −3 | −4 | −4 | 367 | −116 | −136 | −259 | −4 | — |
| Net profit | 0 | 0 | −4 | 3 | −1 355 | 378 | 517 | 482 | −0 | −12 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 835 | 809 | 1 072 | 1 056 | 1 828 | 2 075 | 1 985 | 2 684 | 1 866 | 1 805 |
| Equity | 101 | 252 | 248 | 251 | 696 | 1 074 | 1 591 | 2 074 | 674 | 662 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | 171 |
| Short-term debt | 734 | 557 | 824 | 805 | 1 132 | 1 001 | 394 | 611 | 1 192 | 972 |
| Total debt | 734 | 557 | 824 | 805 | 1 132 | 1 001 | 394 | 611 | 1 192 | 1 142 |
EBITDA margin
5.4%
This company
15.8%
Market median
-66% vs market
20162025
Equity ratio
36.7%
This company
38.2%
Market median
+4% vs market
20162025
Return on equity
-1.8%
This company
18.4%
Market median
-110% vs market
20162025
Net profit margin
-0.2%
This company
8.1%
Market median
-102% vs market
20162025
Asset turnover
2.77×
This company
1.12×
Market median
+147% vs market
20162025
Debt / equity
1.73×
This company
0.62×
Market median
-179% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-09-01 – 2016-08-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MM | Audit | 2026 | — | — |
SK Chief Auditor | Chief Auditor | 2020 | — | — |
KJ Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Cad.esthetics AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Lundmark J Holding AB
Denzir AB Board members of Denzir AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Madeleine Lundström | Audit | 0 companies |
| Sigrid Katarina Söderberg | Chief Auditor | 0 companies |
| Karl Johan Lundmark | Chief Executive Officer | 0 companies |
| Karl-Johan Tobias Johansson | Deputy Board Member | 0 companies |
| Ulf Oskar Emanuel Lindgren | Deputy Board Member | 0 companies |